Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Amylin Raises $175M Through Sale Of Senior Convertible Notes

April 2, 2004

By Aaron Lorenzo

CancerVax Follow-Up Results Show Canvaxin Survival Benefit

April 1, 2004

By Aaron Lorenzo

CancerVax Follow-Up Results Show Canvaxin Survival Benefit

April 1, 2004

By Aaron Lorenzo

Peregrine Presents Positive Preclinical Findings At AACR

March 31, 2004

By Aaron Lorenzo

Peregrine Presents Positive Preclinical Findings At AACR

March 31, 2004

By Aaron Lorenzo

OxiGene Shares Get A Boost From Preclinical Cancer Data

March 30, 2004

By Aaron Lorenzo

OxiGene Shares Get A Boost From Preclinical Cancer Data

March 30, 2004

By Aaron Lorenzo

Recently Formed By Merger, PainCeptor Nets C$23 Million

March 23, 2004

By Aaron Lorenzo

Recently Formed By Merger, PainCeptor Nets C$23 Million

March 23, 2004

By Aaron Lorenzo

Critical Therapeutics Files For Estimated $103.5M IPO

March 22, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.